Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Heron Therapeutics, Inc. HRTX

Full chart Compare
Set alert

Price alert · HRTX

All alert types
0.29 USD +0.01 (+4.64%)

At closeNov 6, 2026, 6:04 PM EST

0.29 0.00 -1.02%

After hours · Nov 6, 6:04 PM ET

0.2766 Day range 0.2958
0.27 52-week range 1.49
YTD
-77.46%
1 year
-73.36%

Financial health

Altman Z-Score

-9.84 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -10.8×
FY 2016: -2.9×FY 2017: -5.0×FY 2018: -10.6×FY 2019: -9.4×FY 2020: -8.5×FY 2021: -4.1×FY 2022: -1.5×FY 2023: -2.1×FY 2024: -17.2×FY 2025: -10.8×
FY 2016 5y median -4.1× FY 2025
P/S 1.4×
FY 2016: 388×FY 2017: 31.8×FY 2018: 24.5×FY 2019: 13.2×FY 2020: 21.7×FY 2021: 10.4×FY 2022: 2.5×FY 2023: 1.8×FY 2024: 1.6×FY 2025: 1.4×
FY 2016 5y median 1.8× FY 2025
P/B 15.1×
FY 2016: -23.4×FY 2017: 7.5×FY 2018: 5.1×FY 2019: 4.8×FY 2020: 8.1×FY 2021: 11.6×FY 2022: 20.1×FY 2023: -6.9×FY 2024: -6.9×FY 2025: 15.1×
FY 2016 5y median 11.6× FY 2025
P/FCF -7.8×
FY 2016: -3.6×FY 2017: -5.7×FY 2018: -9.4×FY 2019: -14.6×FY 2020: -10.0×FY 2021: -4.4×FY 2022: -1.8×FY 2023: -3.9×FY 2024: -9.6×FY 2025: -7.8×
FY 2016 5y median -4.4× FY 2025
EV/EBITDA -18.4×
FY 2016: -3.2×FY 2017: -4.5×FY 2018: -10.7×FY 2019: -9.3×FY 2020: -8.3×FY 2021: -4.5×FY 2022: -2.3×FY 2023: -3.7×FY 2024: -76.2×FY 2025: -18.4×
FY 2016 5y median -4.5× FY 2025
EV/Sales 2.1×
FY 2016: 419×FY 2017: 28.0×FY 2018: 24.2×FY 2019: 12.8×FY 2020: 20.8×FY 2021: 11.2×FY 2022: 3.9×FY 2023: 3.0×FY 2024: 2.7×FY 2025: 2.1×
FY 2016 5y median 3.0× FY 2025
FCF Yield -12.9%
FY 2016: -27.6%FY 2017: -17.7%FY 2018: -10.6%FY 2019: -6.9%FY 2020: -10.0%FY 2021: -23.0%FY 2022: -54.6%FY 2023: -25.7%FY 2024: -10.4%FY 2025: -12.9%
FY 2016 5y median -23.0% FY 2025

Profitability

Gross Margin 73.3%
FY 2016: 97.3%FY 2017: 85.1%FY 2018: 64.5%FY 2019: 57.8%FY 2020: 59.2%FY 2021: 46.7%FY 2022: 49.0%FY 2023: 48.8%FY 2024: 73.2%FY 2025: 73.3%
FY 2016 5y median 49.0% FY 2025
Operating Margin -1.6%
FY 2016: -13363.2%FY 2017: -632.4%FY 2018: -237.4%FY 2019: -144.3%FY 2020: -257.4%FY 2021: -252.3%FY 2022: -162.2%FY 2023: -87.1%FY 2024: -8.0%FY 2025: -1.6%
FY 2016 5y median -87.1% FY 2025
Net Margin -13.0%
FY 2016: -13537.4%FY 2017: -641.9%FY 2018: -230.8%FY 2019: -140.3%FY 2020: -256.4%FY 2021: -255.6%FY 2022: -169.1%FY 2023: -87.0%FY 2024: -9.4%FY 2025: -13.0%
FY 2016 5y median -87.0% FY 2025
ROE -140.9%
FY 2016: 814.8%FY 2017: -150.6%FY 2018: -48.3%FY 2019: -50.7%FY 2020: -96.1%FY 2021: -284.5%FY 2022: -1341.2%FY 2023: 325.4%FY 2024: 40.4%FY 2025: -140.9%
FY 2016 5y median -140.9% FY 2025
ROIC -1.6%
FY 2016: -536.4%FY 2017: -121.7%FY 2018: -49.1%FY 2019: -49.7%FY 2020: -87.4%FY 2021: -91.9%FY 2022: -102.0%FY 2023: -75.8%FY 2024: -8.0%FY 2025: -1.6%
FY 2016 5y median -75.8% FY 2025
ROA -7.9%
FY 2016: -256.6%FY 2017: -84.3%FY 2018: -38.7%FY 2019: -39.9%FY 2020: -64.3%FY 2021: -72.2%FY 2022: -72.5%FY 2023: -49.7%FY 2024: -5.8%FY 2025: -7.9%
FY 2016 5y median -49.7% FY 2025

Growth (YoY)

Revenue 7.4%
FY 2016: 0.0%FY 2017: 2305.6%FY 2018: 151.8%FY 2019: 88.4%FY 2020: -39.3%FY 2021: -2.6%FY 2022: 24.7%FY 2023: 18.0%FY 2024: 13.6%FY 2025: 7.4%
FY 2016 FY 2025
Operating Income 78.0%
FY 2016: -76.3%FY 2017: -13.8%FY 2018: 5.5%FY 2019: -14.5%FY 2020: -8.3%FY 2021: 4.5%FY 2022: 19.8%FY 2023: 36.7%FY 2024: 89.6%FY 2025: 78.0%
FY 2016 FY 2025
EPS (diluted) -34.7%
FY 2016: -54.9%FY 2017: 20.1%FY 2018: 33.2%FY 2019: -2.5%FY 2020: 0.0%FY 2021: 10.4%FY 2022: 25.4%FY 2023: 52.1%FY 2024: 88.9%FY 2025: -34.7%
FY 2016 FY 2025
Free Cash Flow -15.2%
FY 2016: -72.4%FY 2017: -26.0%FY 2018: -16.3%FY 2019: 34.5%FY 2020: -45.5%FY 2021: -7.7%FY 2022: 27.9%FY 2023: 59.4%FY 2024: 59.8%FY 2025: -15.2%
FY 2016 FY 2025

Financial Health

Current Ratio 2.5×
FY 2016: 1.6×FY 2017: 2.2×FY 2018: 4.9×FY 2019: 5.0×FY 2020: 3.1×FY 2021: 3.6×FY 2022: 2.5×FY 2023: 2.4×FY 2024: 2.3×FY 2025: 2.5×
FY 2016 5y median 2.5× FY 2025
Quick Ratio 1.5×
FY 2016: 1.5×FY 2017: 2.1×FY 2018: 4.4×FY 2019: 4.7×FY 2020: 2.7×FY 2021: 2.9×FY 2022: 1.8×FY 2023: 1.8×FY 2024: 1.7×FY 2025: 1.5×
FY 2016 5y median 1.8× FY 2025
Debt / Equity 9.8×
FY 2016: -2.5×FY 2017: 0.2×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.1×FY 2021: 2.1×FY 2022: 11.6×FY 2023: -5.3×FY 2024: -5.3×FY 2025: 9.8×
FY 2016 5y median 2.1× FY 2025
Net Debt / EBITDA -6.3×
FY 2016: -0.2×FY 2017: 0.6×FY 2018: 0.2×FY 2019: 0.3×FY 2020: 0.4×FY 2021: -0.3×FY 2022: -0.8×FY 2023: -1.5×FY 2024: -30.1×FY 2025: -6.3×
FY 2016 5y median -1.5× FY 2025
Interest Coverage 0.0×
FY 2016: -64.2×FY 2017: -49.4×FY 2018: -68.8×FY 2019: -143×FY 2020: -120×FY 2021: -90.4×FY 2022: -70.6×FY 2023: -28.6×FY 2024: -1.9×FY 2025: 0.0×
FY 2016 5y median -28.6× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31